Health-Chem Corporation
HCLC · OTC
6/30/2007 | 3/31/2007 | 6/30/2006 | 3/31/2006 | |
|---|---|---|---|---|
| Revenue | $1,105 | $1,149 | $1,300 | $1,619 |
| % Growth | -3.8% | -11.6% | -19.7% | – |
| Cost of Goods Sold | $1,555 | $1,194 | $1,019 | $1,212 |
| Gross Profit | -$450 | -$45 | $281 | $407 |
| % Margin | -40.7% | -3.9% | 21.6% | 25.1% |
| R&D Expenses | $98 | $118 | $138 | $120 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $996 | $456 | $432 | $429 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,094 | $574 | $570 | $549 |
| Operating Income | $1,739 | $816 | $483 | $350 |
| % Margin | 157.4% | 71% | 37.2% | 21.6% |
| Other Income/Exp. Net | -$1,152 | -$1,338 | -$879 | -$695 |
| Pre-Tax Income | $587 | -$522 | -$396 | -$345 |
| Tax Expense | $0 | $0 | $13 | $0 |
| Net Income | $587 | -$522 | -$409 | -$345 |
| % Margin | 53.1% | -45.4% | -31.5% | -21.3% |
| EPS | 0.05 | -0.046 | -0.036 | -0.03 |
| % Growth | 209.6% | -27.7% | -18.6% | – |
| EPS Diluted | 0.05 | -0.046 | -0.036 | -0.03 |
| Weighted Avg Shares Out | 12,156 | 11,443 | 11,443 | 11,443 |
| Weighted Avg Shares Out Dil | 12,156 | 11,443 | 11,443 | 11,443 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $195 | $197 | $194 | $208 |
| Depreciation & Amortization | $80 | $80 | $80 | $78 |
| EBITDA | $862 | -$245 | -$122 | -$59 |
| % Margin | 78% | -21.3% | -9.4% | -3.6% |